Insider trading · Q3 2026 · CIK 1528287

NeuroPace Inc (NPCE) insider trading.

In Q3 2026, insiders at NeuroPace Inc reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.

Transactions
5
Purchases (P)
0
Sales (S)
0
Net shares, P minus S
0
Insiders
3
Last filed
2026-09-25

Insiders

InsiderRelationshipTransactionsBuysSales
Morrell MarthaOfficer · CHIEF MEDICAL OFFICER200
Becker JoelDirector, Officer · CHIEF EXECUTIVE OFFICER200
Williams Patrick F.Officer · Chief Financial Officer100

Transactions

5 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-24Morrell MarthaF (D)335$13.9751,357Form 4
2026-09-20Williams Patrick F.F (D)1,162$14.2867,508Form 4
2026-09-03Becker JoelF (D)1,310$14.75138,000Form 4
2026-08-27Becker JoelF (D)1,126$14.13139,310Form 4
2026-08-27Morrell MarthaF (D)358$14.1351,692Form 4

Transaction codes in this quarter

Get NPCE insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1528287&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · NPCE company page · NeuroPace Inc on SEC.gov

Questions

Are insiders buying or selling NeuroPace Inc (NPCE)?

In Q3 2026, insiders at NeuroPace Inc reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these NeuroPace Inc insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/npce.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.